Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report

J Dermatol. 2018 Jan;45(1):113-114. doi: 10.1111/1346-8138.13779. Epub 2017 Feb 22.

Authors

Shigeki Numata¹, Yohei Iwata¹, Rie Okumura¹, Masaru Arima¹, Tsukane Kobayashi¹, Soichiro Watanabe¹, Keita Suzuki², Masayuki Horiguchi², Kazumitsu Sugiura¹

Affiliations

¹ Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.
² Department of Ophthalmology, Fujita Health University School of Medicine, Toyoake, Japan.

PMID: 28225147
DOI: 10.1111/1346-8138.13779

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
CTLA-4 Antigen / antagonists & inhibitors
CTLA-4 Antigen / immunology
Facial Paralysis / blood
Facial Paralysis / chemically induced*
Facial Paralysis / diagnosis
HLA-DR4 Antigen / blood
HLA-DR4 Antigen / immunology
Humans
Ipilimumab / adverse effects*
Male
Melanoma / drug therapy
Melanoma / immunology
Melanoma / pathology
Middle Aged
Nivolumab / adverse effects
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology
Uveitis, Anterior / blood
Uveitis, Anterior / diagnosis
Uveitis, Anterior / immunology*
Uveitis, Anterior / pathology

Substances

Antineoplastic Agents, Immunological
CTLA-4 Antigen
CTLA4 protein, human
HLA-DR4 Antigen
Ipilimumab
Nivolumab